Oculis Holding AG Ordinary shares (OCS)

Oculis Holding AG Ordinary shares (OCS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $461M; returns 1 day -2.3%, 1 week +8.4%, 1 year -63.0%.

Oculis Holding AG (OCS) is a global biopharmaceutical company dedicated to developing innovative treatments for significant unmet medical needs in neuro-ophthalmology and ophthalmology. As a clinical-stage company, its business model is centered on the research, development, and eventual commercialization of novel drug candidates.

Groups OCS belongs to

• Biotechnology
• Ophthalmology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Neuroscience
• Healthcare
• Unmet Medical Needs
• Precision Medicine
• Rare Diseases
• Drug Discovery

OCS financial model: income statement, cash flow and balance sheet